Sachs L
Department of Genetics, Weizmann Institute of Science, Rehovot, Israel.
Ciba Found Symp. 1989;142:217-31; discussion 231-3. doi: 10.1002/9780470513750.ch14.
Identification of growth and differentiation-inducing proteins and how they interact in normal development has made it possible to identify the molecular basis of normal development and the mechanisms that uncouple growth and differentiation so as to produce malignant cells. When normal cells have been changed into cancer cells, the malignant phenotype can again be suppressed. Results on the molecular control of growth and differentiation in normal myeloid haemopoietic cells, changes in the normal developmental programme in myeloid leukaemia, and the suppression of malignancy in myeloid leukaemia and sarcomas have shown that (1) malignancy can be suppressed either with or without genetic changes in the malignant cells, (2) suppression of malignancy by inducing differentiation does not have to restore all the normal controls, and (3) genetic abnormalities which give rise to malignancy can be bypassed and their effects nullified by inducing differentiation which stops cells from multiplying.
对生长和分化诱导蛋白的鉴定以及它们在正常发育过程中的相互作用方式,使得确定正常发育的分子基础以及那些使生长与分化解偶联从而产生恶性细胞的机制成为可能。当正常细胞转变为癌细胞后,恶性表型又能够被抑制。关于正常髓系造血细胞生长和分化的分子调控、髓系白血病中正常发育程序的变化以及髓系白血病和肉瘤中恶性肿瘤的抑制等方面的研究结果表明:(1)无论恶性细胞是否发生基因改变,恶性肿瘤都能够被抑制;(2)通过诱导分化来抑制恶性肿瘤并不一定需要恢复所有正常调控;(3)导致恶性肿瘤的基因异常可以被绕过,并且通过诱导分化使细胞停止增殖能够消除其影响。